Big Data in Oncology Spotlight
This week in health care trends, our big data in oncology spotlight includes: articles that discuss how continuing to collect data as technology improves expands understanding, corrects misunderstandings and provides new discoveries.
“This major infusion of data in the GDC will greatly enhance our ability to use this tool to explore genetic abnormalities in cancer,” said Douglas Lowy, M.D., NCI Acting Director.
This article reports on a new study that has found evidence that brain tumours use fat as their preferred source of energy, bringing into question the decades-long assumption that sugar is their main fuel source.
The study reported on in this article outlines the incidental discovery of a leukaemia drug that is creating opportunities for the battle against a rare type of ovarian cancer.
Several associations are supportive of the VBP concept, but question how practical it would be to implement and practice. This article outlines the issues.
In this article, Robert S. Miller, MD, FACP, FASCO, and Medical Director of CancerLinQ at ASCO shares the benefits and objectives of CancerLinQ.
The articles above are from our dedicated Big Data in Oncology e-magazine. You can follow us on Flipboard or Twitter, or just watch for the links to this and our other magazines in our regular BioBlog emails. (Don’t get our emails yet? Subscribe here!)